Incorporating genetic susceptibility feedback into a smoking cessation program for African-American smokers with low income.

PURPOSE Markers of genetic susceptibility to tobacco-related cancers could personalize harms of smoking and motivate cessation. Our objective was to assess whether a multicomponent intervention that included feedback about genetic susceptibility to lung cancer increased risk perceptions and rates of smoking cessation compared with a standard cessation intervention. EXPERIMENTAL DESIGN Our design was a two-arm trial with eligible smokers randomized in a 1:2 ratio to Enhanced Usual Care or Biomarker Feedback (BF). Surveys were conducted at baseline, 6, and 12 months later. The setting was an inner city community health clinic. African-American patients who were current smokers (n = 557) were identified by chart abstraction and provider referral. All smokers received a self-help manual and, if appropriate, nicotine patches. Smokers in the BF arm also were offered a blood test for genotyping the GST(3) gene (GSTM1), sent a test result booklet, and called up to four times by a health educator. Prevalent abstinence was assessed by self-report of having smoked no cigarettes in the prior 7 days at the 6- and 12-month follow-ups and sustained abstinence, i.e., not smoking at either follow-up or in-between. RESULTS Smoking cessation was greater for the BF arm than the Enhanced Usual Care arm (19% versus 10%, respectively; P < 0.006) at 6 months but not at 12 months. CONCLUSIONS Smokers agreed to genetic feedback as part of a multicomponent cessation program. Although the program increased short-term cessation rates compared with standard intervention, genetic feedback of susceptibility may not benefit smokers with high baseline risk perceptions.

[1]  J. Prochaska,et al.  Stages and processes of self-change of smoking: toward an integrative model of change. , 1983, Journal of consulting and clinical psychology.

[2]  E. Wagner,et al.  Smokers and drinkers in a health maintenance organization population: lifestyles and health status. , 1987, Preventive medicine.

[3]  K. Comstock,et al.  GST1 gene deletion determined by polymerase chain reaction. , 1990, Nucleic acids research.

[4]  J. Samet.  Health benefits of smoking cessation. , 1991, Clinics in chest medicine.

[5]  D. Murray,et al.  Sensitivity and specificity of saliva thiocyanate and cotinine for cigarette smoking: a comparison of two collection methods. , 1991, Addictive behaviors.

[6]  J. Samet.  The health benefits of smoking cessation. , 1991, The Medical clinics of North America.

[7]  T. Glynn,et al.  Smoking Cessation among Blacks , 2010, Journal of health care for the poor and underserved.

[8]  W. Miller,et al.  Motivational Interviewing: Preparing People to Change Addictive Behavior , 1991 .

[9]  G. Connolly.  Worldwide expansion of transnational tobacco industry. , 1992, Journal of the National Cancer Institute. Monographs.

[10]  W F Velicer,et al.  Assessing outcome in smoking cessation studies. , 1992, Psychological bulletin.

[11]  T. Hartwell,et al.  Smoking cessation factors among African Americans and whites. COMMIT Research Group. , 1993, American journal of public health.

[12]  V. Gamble.  A legacy of distrust: African Americans and medical research. , 1993, American journal of preventive medicine.

[13]  M. Spitz,et al.  Mutagen sensitivity as a biological marker of lung cancer risk in African Americans. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[14]  T. Rebbeck,et al.  Assessment and counseling for women with a family history of breast cancer. A guide for clinicians. , 1995, JAMA.

[15]  K. Richert-Boe,et al.  Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[16]  E H Wagner,et al.  A randomized trial of self-help materials, personalized feedback, and telephone counseling with nonvolunteer smokers. , 1995, Journal of consulting and clinical psychology.

[17]  Timothy B. Baker,et al.  THE AGENCY FOR HEALTH CARE POLICY AND RESEARCH SMOKING CESSATION CLINICAL PRACTICE GUIDELINE , 1996 .

[18]  L. Parker,et al.  Standards of care and ethical concerns in genetic testing and screening. , 1996, Clinical obstetrics and gynecology.

[19]  B. Wilfond,et al.  Incorporating biomarkers of exposure and genetic susceptibility into smoking cessation treatment: effects on smoking-related cognitions, emotions, and behavior change. , 1997, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[20]  K. Resnicow,et al.  A Self-Help Smoking Cessation Program for Inner-City African Americans: Results from the Harlem Health Connection Project , 1997, Health education & behavior : the official publication of the Society for Public Health Education.

[21]  D. E. Roberts.  The nature of Blacks' skepticism about genetic testing. , 1997, Seton Hall law review.

[22]  V. Hasselblad,et al.  Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research. , 1997 .

[23]  T. Rebbeck.  Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[24]  C. McBride,et al.  Use of Self-Help Materials and Smoking Cessation among Proactively Recruited and Volunteer Intervention Participants , 1998, American journal of health promotion : AJHP.

[25]  N. Weinstein.  Accuracy of smokers' risk perceptions , 1998, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[26]  W. S. Clark,et al.  Knowledge about smoking, reasons for smoking, and reasons for wishing to quit in inner-city African Americans. , 1998, Ethnicity & disease.

[27]  K. Crittenden,et al.  Evaluation of a motivational smoking cessation intervention for women in public health clinics. , 1999, Preventive medicine.

[28]  J. Benkendorf,et al.  Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[29]  B. Rimer,et al.  Using tailored interventions to enhance smoking cessation among African-Americans at a community health center. , 1999, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[30]  H. Bartsch,et al.  Genetic cancer susceptibility and DNA adducts: studies in smokers, tobacco chewers, and coke oven workers. , 1999, Cancer detection and prevention.

[31]  I. Lipkus,et al.  Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[32]  D. Bowen,et al.  Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[33]  B. Rimer,et al.  Using the telephone to improve health behavior and health service delivery. , 1999, Patient education and counseling.

[34]  State-specific prevalence of current cigarette smoking among adults and the proportion of adults who work in a smoke-free environment--United States, 1999. , 2000, MMWR. Morbidity and mortality weekly report.

[35]  G Bepler,et al.  Maximizing the motivational impact of feedback of lung cancer susceptibility on smokers' desire to quit. , 2000, Journal of health communication.

[36]  Richard Doll,et al.  Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies , 2000, BMJ : British Medical Journal.

[37]  Maximizing the Motivational Impact of Feedback of Lung Cancer Susceptibility on Smokers' Desire to Quit , 2000 .

[38]  T. Marteau,et al.  Genetic risk and behavioural change , 2001, BMJ : British Medical Journal.

[39]  Jennifer M. Heisler,et al.  Readiness to Change Smoking Behavior in a Community Health Center Population , 1997, Journal of Community Health.